Kytopen
Cambridge, United States · Founded 2017 · $42.8M raised
- Headquarters
- Cambridge
- Founded
- 2017
- Website
- kytopen.com
- Total Funding
- $42.8M
- Last Round
- $1.6M Series BApr 2026
- Rounds
- 8
About
Cell engineering platform for faster gene delivery
Summary
Kytopen is a Biotechnology company based in Cambridge, United States, founded in 2017. It has raised $42.8M in total across 8 rounds, most recently a $1.6M Series B round in Apr 2026. Investors include MassVentures, Northpond Ventures and Telegraph Hill Capital.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Apr 2026
Sign up to see all 8 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Leading innovative radiopharmaceutical company in China developing next-generation radiopharmaceu...
Clinical-stage biotechnology company pioneering GPCR drug discovery through its proprietary Nativ...
Clinical-stage ophthalmic gene therapy company developing AAV-based treatments for rare and preva...
Belgian agricultural biotech company developing microbial-based biocontrol and biostimulant produ...
Clinical-stage biotechnology company developing in vivo CRISPR gene editing therapies for severe ...
Biotech company developing novel GPCR-targeting therapeutics using conformation-specific nanobodies.